title: [Informed consent for patients on early recognition of prostate carcinoma is insufficient].
abstract: Men that undergo an early detection investigation should be informed of the advantages and disadvantages as well as of the therapeutic consequences. In this study the quality of information was checked using the state of scientific knowledge of the patients.An informative consultation was carried out before the early detection investigation using a clarification brochure and an examination by a urologist. A questionnaire was also filled out after the investigation. A total of 1,536 men were questioned. Although 47% of the men had previously undertaken a PSA at least once, only 55% knew their own test result. Subjectively 82% of men felt well informed. In contrast one-third did not know the significance of an increased PSA level. In the field of patient clarification for the early detection for prostate cancer there are considerable deficits but the information received was considered adequate by the participants. However, more than one-third did not understand the significance of the PSA level.
authors.affiliation: Klinik und Poliklinik für Urologie, Universitätsklinik, Hufelandstrasse 55, 45122, Essen, Germany. christof.boergermann@uk-essen.de
authors.forename: C
authors.initials: C
authors.lastname: Börgermann
authors.forename: F
authors.initials: F
authors.lastname: vom Dorp
authors.forename: R
authors.initials: R
authors.lastname: Rossi
authors.forename: M
authors.initials: M
authors.lastname: Schenck
authors.forename: H-J
authors.initials: HJ
authors.lastname: Luboldt
authors.forename: H
authors.initials: H
authors.lastname: Rübben
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005858:Germany / Q000453:epidemiology; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007258:Informed Consent / Q000706:statistics & numerical data*; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data*; D008875:Middle Aged; D010353:Patient Education as Topic / Q000706:statistics & numerical data*; D017060:Patient Satisfaction / Q000706:statistics & numerical data*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D018570:Risk Assessment; D012307:Risk Factors; D011795:Surveys and Questionnaires
chemical_list: D017430:Prostate-Specific Antigen
references.citation: N Engl J Med. 2009 Mar 26;360(13):1310-9
references.pmid: 19297565
references.citation: N Engl J Med. 2009 Mar 26;360(13):1320-8
references.pmid: 19297566
references.citation: Health Psychol. 2006 Mar;25(2):135-143
references.pmid: 16569104
references.citation: Br J Urol. 1995 May;75(5):631-6
references.pmid: 7613800
references.citation: Crit Rev Oncol Hematol. 2004 Apr;50(1):71-8
references.pmid: 15094160
references.citation: J Natl Cancer Inst. 1998 Jun 17;90(12):925-31
references.pmid: 9637143
references.citation: Cancer. 2002 Jun 1;94(11):2923-9
references.pmid: 12115380